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Abstract
Background: Interstitial 6q deletions, involving the 6q15q25 chromosomal region, are rare events characterized by
variable phenotypes and no clear karyotype/phenotype correlation has been determined yet.
Results: We present a child with a 6q21q22.1 deletion, characterized by array-CGH, associated with developmental
delay, intellectual disability, microcephaly, facial dysmorphisms, skeletal, muscle, and brain anomalies.
Discussion: In our patient, the 6q21q22.1 deleted region contains ten genes (TRAF3IP2, FYN, WISP3, TUBE1, LAMA4,
MARCKS, HDAC2, HS3ST5, FRK, COL10A1) and two desert gene regions. We discuss here if these genes had some role
in determining the phenotype of our patient in order to establish a possible karyotype/phenotype correlation.
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Background
Interstitial deletions of the long arm of chromosome 6
are rare and are divided into proximal (6q11q16), medial
(6q15q25), and terminal (6q25qter) based on conven-
tional cytogenetics [1]. Approximately, less than 30 pa-
tients with intermediate 6q interstitial deletions, studied
by standard cytogenetics and array-CGH, have been re-
ported [2-13].
The phenotype of patients with medial 6q deletion is
generally associated with intrauterine growth retardation
(IUGR), abnormal respiration, hypertelorism, and upper
limb malformations [1]. However, the patients described
to date presented a large spectrum of clinical features,
depending on the size of the deleted segment, the involved
genes, and the genomic architecture of the region, making
genotype–phenotype correlation difficult.
Here, we report on the phenotypic and molecular
characterization of a new 6q21q22.1 deletion in a boy
with developmental delay, intellectual disability, micro-
cephaly, facial dysmorphisms, and skeletal, muscle, and
brain anomalies. We compare the phenotype of our
patient with that of previously reported patients and
discuss the role of the deleted genes in order to establish
a possible karyotype/phenotype correlation.
Case presentation
The patient, a 13-year-old boy, is the only child of non-
consanguineous, healthy Paraguayan parents. The child
was born at term by elective caesarean section after an
uneventful pregnancy. Birth weight was 4060 g and no
perinatal diseases were reported. Data on the patient’s
history as a child are not available because he lived in
Paraguay with his grandparents, however delay in psy-
chomotor development was reported (he was able to sit
without support at 8 months and to walk at 18 months).
At 12 years, he moved to Italy to join his mother and at
13 years he was admitted to our hospital because of mild
intellectual disability and dysmorphic features.
Neurological examination demonstrated mild clumsiness
without obvious focal signs. On physical examination, his
weight was 42.8 Kg (50-75th percentile), height 161 cm
(75-90th percentile), and head circumference 52 cm (3rd-
10th percentile). He showed facial dysmorphisms (hyperte-
lorism, wide and flat nose), pectus excavatum and chest
asymmetry. The absence of pectoralis major and minor
muscles on the right side was demonstrated by ultrasound
imaging and the diagnosis of Poland Syndrome (PS) (MIM
173800) was made. Standing X-ray films of the full-length
spine showed thoracolumbar scoliosis, without vertebral
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abnormalities (Figure 1A). No additional anomalies of
the kidney, urinary tract, or heart were detected by
ultrasound examination. Ophthalmologic evaluation dem-
onstrated intermittent exotropia, bilateral myopia, and
normal fundus oculi. Brain magnetic resonance imaging
(MRI) showed cerebellar vermis hypoplasia (Figure 1B, C).
Neurophysiological studies including electroencephalo-
gram (EEG) and brainstem auditory evoked potentials
(BAEP) resulted normal.
Cognitive impairment was revealed by psychometric
evaluation (<5th centile at Raven’s Progressive Matrices
P.M.38).
Results
Cytogenetic analysis, performed on GTG-banded meta-
phases from cultured lymphocytes of the patient and his
mother, showed normal karyotypes. Considering the
phenotypic abnormalities of the patient, array-CGH ana-
lysis was performed, showing a 4.71 Mb interstitial deletion
at 6q21q22.1 bands. The deletion spanned from genomic
position 111,884,640 Kb to 116,594,641 Kb (Additional
file 1: Figure S1). The 6q21 deleted region includes 8
OMIM genes: TRAF3IP2 (MIM 607043) traf3-interacting
protein 2; FYN (MIM 137025) fyn oncogene related to
SRC, FGR, YES; WISP3 (MIM 603400) WNT1-inducible
signalling pathway protein 3;TUBE1 (MIM 607345)
tubulin, epsilon-1; LAMA4 (MIM 600133) laminin, alpha-
4; MARCKS (MIM 177061) myristoylated alanine-rich
protein kinase c substrate; HDAC2 (MIM 605164) histone
deacetylase 2; HS3ST5 (MIM 609407) heparansulfate (glu-
cosamine) 3-o-sulfotransferase 5. The deletion also con-
tains a 1.5 Mb gene desert region that, conversely, is
characterized by the presence of several large intergenic
non coding RNAs (lincRNAs) and of transcripts of uncer-
tain coding potential (TUCPs), according to The Human
Body Map catalogue [14,15]. The 6q22.1 deleted region
includes a 1.878 Mb desert region and 2 OMIM genes:
FRK (MIM 606573) fyn-related kinase; COL10A1 (MIM
120110) collagen, type X, alpha-1 (Figure 2).
Array-CGH analysis performed on peripheral blood of
the mother was normal.
Discussion
We report on a 13-year-old boy presenting developmental
delay, intellectual disability, microcephaly, facial dysmorph-
isms, and skeletal, muscle, and brain anomalies. Array-
CGH identified a 4.71 Mb interstitial deletion at 6q21q22.1
bands. Rosenfeld et al. [8] described 12 individuals with
variable deletions within 6q15q22.33 and compared their
clinical features to better define karyotype/phenotype cor-
relations. They reported heterogeneous phenotypes, even
among individuals with overlapping deletions. They specu-
lated that phenotypic variability could be related to less
penetrance, concomitant mutations in other genes, in non-
coding regions, such as transcription factor binding sites,
or in methylation patterns.
Figure 1 X-ray and MRI analyses of the patient. A) Standing X-ray films of full-length spine. Front view showing thoracolumbar scoliosis and side
view demonstrating pectus excavatum (open arrow). No associated vertebral abnormalities are present. B, C) Brain MRI.) Midsagittal T1-weighted
image demonstrating moderate vermis hypoplasia (B). Coronal T2-weighted image showing normal cerebellar hemispheres (C).
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Searching for patients with similar chromosomal im-
balances, we select the patient n.6 reported by Rosenfeld
et al. (2012) [8] and, in the DECIPHER database (DE-
CIPHER, https://decipher.sanger.ac.uk/), another 2 pa-
tients (n.257884, n.2498) sharing part of the deleted
region with ours.
A comparison of our patient’s phenotype with those
reported in the literature and in DECIPHER database is
shown in Table 1. All the patients were studied by array-
CGH. Microcephaly, developmental delay, intellectual
disability, and skeletal and ophthalmologic features were
common among these patients. Interestingly, our patient
also showed some features of Poland syndrome (PS) as
the absence of pectoralis major and minor muscles on
the right side.
We consider the deleted region (chr6:113,190,061-
114,450,408) shared by our case, patient n.6 [8], and the
two DECIPHER cases, n.257884 and n.2498 (Figure 2).
It contains three genes: MARCKS, HDAC2, and HS3ST5.
It is known that MARCKS (myristoylated alanine-rich C
kinase substrate) encodes an actin cross-linking protein
that plays a role in signal transduction pathways, postnatal
survival, cellular migration and adhesion, as well as endo-,
exo-, and phagocytosis, and neurosecretion. Moreover,
MARCKS is expressed in brain and spinal cord from the
early stages of development. It is required during embryo-
genesis, as revealed by several gene knock-out studies:
mice heterozygous for MARCKS appear normal, but ex-
hibit impaired spatial learning while mice lacking the
entire MARCKS gene show severe abnormalities of the
central nervous system, and all die around birth [16].
The HDAC2 (Histone deacetylase 2) gene encodes a
transcription factor that enhances cognitive ability, corrects
neurodegenerative impairment, and helps to re-establish
long-term memory [17].
HS3ST5 gene encodes a protein that belongs to a group
of heparansulfate 3-O-sulfotransferases highly expressed
in fetal brain, followed by adult brain and spinal cord [18].
Since these three genes are involved in neural develop-
ment, we could speculate that their deletion could cause
neurological phenotypes like developmental delay, intel-
lectual disability, and brain malformations, all observed
in our patient and in the other three similar patients as
shown in Table 1.
Moreover, in our patient, the genomic 6q21q22.1 deleted
region contained another seven OMIM genes, including
FYN, WISP3,and COL10A1. FYN is a non-receptor tyro-
sine kinase belonging to the Src family kinases. It proved
to play important roles in neuronal functions, including
myelination and oligodendrocyte formation, and in inflam-
matory processes [19]. WISP3 encodes a member of the
CCN (connective tissue growth factor, Cysteine-rich 61,
nephroblastoma overexpressed) family of connective tissue
growth factor, known to be mostly extracellular matrix-
associated proteins, involved in regulation of cell migra-
tion and adhesion, cell proliferation, differentiation, and
survival in connective tissues. It is expressed in skeletal-
derived cells, such as synoviocytes, chondrocytes, and
bone marrow-derived mesenchymal progenitor cells, and
it is involved in skeletal development and maintenance of
cartilage integrity [20]. COL10A1 encodes type X collagen
specifically expressed by hypertrophic chondrocytes. As a
Figure 2 Overview of the region 6q21q22.1 and its gene content according to the UCSC Genome Browser [GRCh37/hg19 assembly]. The bars
indicate the deleted region in our patient, in Rosenfeld et al. case n.6, in DECIPHER case n.257884, and in DECIPHER case n.2498.
Tassano et al. Molecular Cytogenetics  (2015) 8:31 Page 3 of 6
major component of the hypertrophic zone, type X colla-
gen influences the deposition of other matrix molecules in
this region, thereby providing a proper environment for
haematopoiesis, mineralization, and modelling, that are
essential for endochondral ossification. Mutations and
abnormal expression of COL10A1 are closely linked to
abnormal chondrocyte hypertrophy, which has been
observed in multiple skeletal dysplasia and osteoarth-
ritis [21]. For these reasons, we could speculate that, in
our patient, haploinsufficiency of FYN could have contrib-
uted to neurological anomalies, and WISP3 and COL10A1
to skeletal defects.
To date, the pathogenic mechanisms underlying PS
are still unknown and the genetic origin of the disease is
Table 1 Phenotype and molecular comparison
Our case Case n.6 Rosenfeld et
al. 2012
Decipher n. 257884 Decipher n. 2498
Gender M M F ND













Unknown De novo ND
Weight 50-75th 55th −2 DS (14 kg) +0.4 SD
Height 75-90th 50th −1 DS (104 cm) −1.2 SD
OFC 3rd-10th −1,4 SD −2 DS (48 cm) −7.2 SD
DD + + + +
ID + + + +
Hypotonia - - Moderate Right hemiplegia with
brisk reflexes and
spasticity




Reduction in volume in
the left hemi cranium
with cystic
cerebromalacia.
Cortical dysplasia Thin corpus callosum
Other neurological
features









Dysmorphic features Hypertelorism, wide and
flat nose
Hypertelorism, wide nasal







Limbs - Long and slender fingers
and toes
ND -




Pectus carenatum ND Required reconstruction
of right hip probably
secondary to hemiplegia
Muscle features Absence of the pectoralis
major and minor muscles
(Poland Syndrome)
- ND -













MARCKS, HDAC2, HS3ST5 MARCKS, HDAC2, HS3ST5 MARCKS, HDAC2, HS3ST5
ND = not determined; OFC = Occipitofrontal Circumference; DD = developmental delay; ID = intellectual disability.
Tassano et al. Molecular Cytogenetics  (2015) 8:31 Page 4 of 6
still a matter of debate. It has been hypothesized that PS
defects could result from a vascular insult during early
embryological stages, which implies that environmental
factors could contribute to PS phenotype [22,23].
Conclusions
Interstitial 6q deletion can cause a variable phenotype
depending on the size and location of the anomaly. Our
paper may contribute to a better understanding of karyo-
type/phenotype correlation in cases with deletion in
6q21q22.1 and to determine the clinical implication of the
genes present in the involved chromosomal region. Identi-
fication of additional individuals with overlapping intersti-
tial deletion will help to better define this correlation.
Methods
Standard GTG banding was performed at a resolution of
400–550 bands on metaphase chromosomes from per-
ipheral blood lymphocytes of the patient and his mother;
the father refused any analysis. Molecular karyotyping was
performed in the patient and his mother using Human
Genome CGH Microarray Kit G3 180 (Agilent Technolo-
gies, Palo Alto, USA) with ~13 Kb overall median probe
spacing. Labelling and hybridization were performed fol-
lowing the protocols provided by the manufacturers. A
graphical overview was obtained using Agilent Genomic
Workbench Lite Edition Software 6.5.0.18.
Consent
Written informed consent was obtained from the patient’s
parents for publication of this paper and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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